<unk>  GLAR geen, sold under the brand name Lantus among others, is a long-acting insulin, used in the management of type I and type II diabetes. It is typically the recommended long acting insulin in the United Kingdom. It is used once a day as an injection just under the skin. Effects generally begin an hour after use. Common side effects include low blood sugar, problems at the site of injection, itchiness, and weight gain. Other serious side effects include low blood potassium. NPH insulin rather than<unk>  is generally preferred in pregnancy. After injection microcrystals slowly release insulin for about 24 hours. This insulin causes body tissues to absorb glucose from the blood and decreases glucose production by the liver.<unk>  was approved for medical use in the United States in 2000. It is on the World Health Organization's List of Essential Medicines. In 2019, it was the 36th most commonly prescribed medication in the United States with more than 19million prescriptions.
Insulin glargine
Insulin aspart
Insulin glulisine
Lente insulin
Regular insulin
Insulin detemir
NPH insulin
Insulin lispro